Loading
BI
Biosenta Inc. Stock: price and insider trades · Canada
Insider Decl.
62
Thresholds
n/a
Buy Volume
€12,363
12 ops. · all time
Sell Volume
€93,860
5 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
CA$0.04
Analyst consensus
Income statement
RevenueCA$1.2k
Gross profitCA$56747% margin
EBITDA-CA$1.4M-114521% margin
Net income-CA$2.5M-206924.4% margin
Valuation
Beta0.33
Balance sheet & cash
Market capCA$1.4M
Total debtCA$694.6k
Free Cash Flow-CA$481.2k
Profitability & ownership
ROA-766.6%
% insiders12.0%
% institutions0.0%
Last declaration on 11 October 2024
Declarations62 total
20,000 shares@ CA$0.06Common Shares Class A Common SharesTSXSEDI:4389776
Canonical exit: 8 Jan 2025 (T+90)
44,000 shares@ CA$0.084Common Shares Class A Common SharesTSXSEDI:4383511
Canonical exit: 31 Dec 2024 (T+90)
557,143 shares@ CA$0.4919.0% of flowCommon Shares Class A Common SharesTSXSEDI:4303126
106,716 shares@ CA$0.4012.7% of flowCommon Shares Class A Common SharesTSXSEDI:4289028
106,716 shares@ CA$0.4012.8% of flowCommon SharesTSXSEDI:4289069
181,265 shares@ CA$0.4040.2% of flowCommon Shares Class A Common SharesTSXSEDI:4262125
267,955 shares@ CA$0.40100.0% of flowCommon SharesTSXSEDI:4262095
1,250,000 shares@ CA$0.4086.8% of flowCommon Shares Class A Common SharesTSXSEDI:4262215
500 shares@ CA$0.300.0% of flowCommon Shares Class A Common SharesTSXSEDI:4260013
Canonical exit: 15 May 2024 (T+90)
6,000 shares@ CA$0.300.1% of flowCommon Shares Class A Common SharesTSXSEDI:4168939
Canonical exit: 9 Nov 2023 (T+90)
2,000 shares@ CA$0.3820.1% of flowCommon Shares Class A Common SharesTSXSEDI:4168945
Canonical exit: 9 Nov 2023 (T+90)
4,000 shares@ CA$0.380.1% of flowCommon Shares Class A Common SharesTSXSEDI:4168943
Canonical exit: 9 Nov 2023 (T+90)
2,000 shares@ CA$0.380.1% of flowCommon Shares Class A Common SharesTSXSEDI:4168948
Canonical exit: 9 Nov 2023 (T+90)
376,603 shares@ CA$0.28Common SharesTSXSEDI:3913613
Common SharesTSXSEDI:4161172
188,302 shares@ CA$0.569.2% of flowCommon SharesTSXSEDI:4161369
188,302 shares@ CA$0.56100.0% of flowCommon SharesTSXSEDI:4161180
1,500,000 shares@ CA$0.4063.9% of flowCommon Shares Class A Common SharesTSXSEDI:4159619
1,500,000 shares@ CA$0.4052.1% of flowCommon SharesTSXSEDI:4159635
1,109,000 shares@ CA$0.10Common Shares Class A Common SharesTSXSEDI:4035488
1,109,000 shares@ CA$0.10Common SharesTSXSEDI:4035669
200,000 shares@ CA$0.48Common Shares Class A Common SharesTSXSEDI:4035459
554,500 shares@ CA$0.20Common Shares Class A Common SharesTSXSEDI:4035496
Common Shares Class A Common SharesTSXSEDI:4035452
549,938 shares@ CA$0.20Common Shares Class A Common SharesTSXSEDI:4035463
25 of 62 declarations
About Biosenta Inc.
Over half of the 49 filings at Biosenta Inc. are of a kind other than purchase or sale: 29, next to 8 purchases, 5 sales, 5 option exercises and 2 grants. The 5 sales weigh EUR 93,860 (median EUR 14,384), against EUR 6,116 for the 8 purchases, 7 of them with an amount: 62% of open-market trades are purchases, but by count only. The three largest sales are Dene Rogers's, senior officer of the issuer, in June 2021: EUR 39,379 on June 2, EUR 23,814 on June 4 and EUR 14,384 on June 8. Amarvir Gill, director and senior officer, has 12 filings including 8 purchases, but the largest do not exceed EUR 1,370 (July 31, 2020), EUR 1,364 (July 3, 2020) and EUR 1,219 (August 11, 2023). William Connor (9 filings) and Paul Kalata (8), both 10% holders, neither bought nor sold. The 8 filers publish between May 31, 2016 and April 19, 2024, with 13 filings in 2016 and 10 in 2023, a median of 2 days after the trade. The Canadian company, listed in Toronto, is worth CAD 1.4 million, with 12% held by insiders. No filing falls in the last twelve months.
